Showing posts with label epigallocatechin. Show all posts
Showing posts with label epigallocatechin. Show all posts

Wednesday, July 16, 2014

Characterization of human thioredoxin system and the potential cellular responses encoded to observe the Thioredoxin-Trx1 reversibly regulated redox sites.

Thioredoxin: human TXN, is a oxidoreductase enzyme in the status of a 12 kDa cellular redox-reductase reaction (70-kDa in bacteria, fungi and plants), a cellular defense mechanisms against oxidative stress of the cell, and numerous cytosolic processes in all cells. Txn1 is a pleiotropic cellular causative gene factor which has numerous functions. Chromosome 3p12-p11 shares homology with human thioredoxin gene Trx1, Trx80: 9q31.3; (§, ). Here the following reaction is the possible mechanisms of the thioredoxin-catalyzed reduction and re-oxidation of its characteristic cystine residues.
 The TXN gene, consists of the first of 5 exons separated by 4 introns and is located 22 bp downstream from the only known basal TATA box factor TBP-2/TXNIP vitamin D(3) up-regulated protein 1-VDUP1, negatively regulating TRX function, and exhibiting cellular growth and suppressive (cancer) activity.
 TRX inhibited Apoptosis signal-regulating kinase-ASK1 kinase (MAP3K5), activity, dependent on two cysteine residues in the N-terminal domain of ASK1 on the redox (regulation) forming intramolecular disulfide between the status of TXN. Two cysteine residues (N-terminal C32S or Trx C-terminal C35S and/or a Trx-CS double mutation) remaining trapped with the Ask1 as a inactive high-molecular-mass complex, blocking its reduction to release Trx from ASK1 depends on intramolecular disulfide to catalyze the reduction of the redox regulation of TRX. Trx and a thiol-specific antioxidant thioredoxin peroxidase-2 orthologue (Tpx) in various* biological phenomena is involved in redox regulation (NADPH-the thioredoxin system) of the dithiol-disulfide active site.
 An apoptosis signal transduction pathway through stimulus-coupled S-nitrosation of cysteine, has two critical (almost identical) cysteine residues in the Trx redox-active center. Where a disulfide exchange reaction between oxidized Txnip [thioredoxin-interacting protein; mouse Vdup1] and reduced TXN occurs. Txnip (-when used to investigate cardiac hypertrophy) is a regulator of biomechanical signaling. Hydrogen peroxide downregulated expression is the only known function associated with an incomplete TRX response through stimulus-coupled S-nitrosation of cysteine residues. Peroxiredoxin PrxIII-'Tpx1 serves as' a tandem (dimer) thioredoxin (Trx2) and NADP-linked thioredoxin reductase (TRR2-TxnR1), are Trx mechanisms of the two electron donor system.
 Cytosolic caspase-3 was maintained by S-nitrosation, consistent with cytosolic and mitochondria, Trx-1 contain equivalent Trx systems, which enabled identification of caspase-3 substrates where TXN may regulate S-nitrosation with the redox center of TXN specific (C73S) to Nitric oxide-NO cellular signal transduction associated with  inhibition of apoptosis or mutant Trx neurotoxicity. EGCG° (epigallocatechin-3-gallate) may be useful in cell survival on caspase-(3_dependent)-neuronal apoptosis where a membrane reaction, a reduced hormesis consequently triggers the apoptosis effect and direct or indirectly numerous protein-protein interactions and basal cofactor substrates which occur between caspase-3 and Trx. The effect of  exercise training via activation of caspase-3 has a decrease in superoxide, and increase of Trx-1 levels in brain. Protection from mechanical stress identified, NSF- N-ethylmaleimide transduced into a TRX peroxidase response via mechanical force of a typical transnitrosylated  Casp3, attenuated  Trx1 2-cysteines which directly transnitrosylates Peroxiredoxins. C32S ( redox potential) was identified as thiol-reducing system, which lacks reducing activitiy (non-active C69S and Cys(73) both monomeric) or a reversible regulating function in the presence of caspase 3 activity is a process found in the presence of NADP and TrxR.
 There are at least two thioredoxin reductive or oxidative** (reductases / peroxiredoxin) regulated systems. The mutant 32CXXC35' motif of thioredoxin nitrosation sites, where two cysteines are separated by two other amino acids, and codes for an additional three cysteines where the Cys 62/C73S (not monomers) sidechain the active site of Cys 62 also can form several disulphides and be modified by the carbon-bonded sulfhydryl, where the  thiol reducing system, was evident.
 Intracellular TRX/ADF (Adult T cell leukemia-derived factor HTLV-I) can regulate cell nuclei, protein-nucleic acid interactions. Transnitrosylation and denitrosylation is a reversible Post-translational (PTM) altered by redox modification of different cysteine residues (C32-73S) in Trx1, S-nitrosation or its interactions with other proteins and DNA-dependent nuclear processes. NFKappaB - REF-1 redox factor 1  involving Cys62, in the two complexes, are correlated as N ⇔ C-terminal responses with  TRX-1 nuclear migration through the reduction of a pleiotropic cellular factor. TRX redox activities of protein-protein cysteine residues is identical to a DNA repair enzyme through various cytoplasmic aspects mediating cellular responses in the 'nucleus'. The DNA binding activity and transactivation of 'AP-1' activator proteins (JUN-proto* oncogen) depends on the reduction between the sulfhydryl of cysteines to keep Trx1 reduced, is demonstrated in cells. Selenium-dependent seleneocysteine based peroxidase reductants, reduce Lipoic acid stereoselectively under the same TRX rather than GSH-PX1-glutathione peroxidase oxidative stress conditions. Sense-antisense (TRX) antiapoptoitic interactions nitrosylated at Cys73 are attenuated and integrated into the host cell under oxidative conditions, in which thioredoxin (TRX), and a cellular TRX reducing catalyst agent (DTT-redox reagent) to S-nitrosoglutathione (GSNO) intermediate via cysteine residues 'influences'-catalyst mediated (post-translational modifications) PTMs; and possibly 1,25D(3)-Calcitriol; NADPH:oxygen oxidoreductases correlated with  (Trx-1) a protein disulfide oxidoreductase.
 Peroxynitrite** converts superoxide to hydrogen peroxide (H2O2)-induced Trx degradation, in concentrations that detoxify reactive oxygen species (ROS), demonstrated by superoxide dismutases (SOD)-catalase: and peroxidases, converting superoxide to hydrogen peroxide which is decomposed to water plus oxidized thioredoxin to maintain the anti-apoptotic (C62) function of thioredoxins additional five sulfhydryl group thiols in the fully reduced state, in a Trx-dependent manner. Reactive oxygen species (ROS) can cause DNA damage, and uncontrolled cellular proliferation or apoptotic death of cancer cells.The NADPH (Trx system) oxidizing substrate-dependent reduction of Thioredoxin reductase-TrxR has a reversibly modulated role in restoration of GR (glucocorticoid receptor) function, and DNA binding domain.

(Click on image to Zoom)
  1XOB Secreted Trx may participate in removing inhibitors of collagen-degrading metalloproteinases. PMID: 14503974 the molecular mechanisms underlying functional the TR1-Trx1 redox pair and structure determination of an active site of the ligand mini-stromelysin-1 TR-1 augmentation composed of TR (Trx reductase activities) the main function of TR1 here is to reduce Trx1 also validated as a ligand PMID; 23105116, have been characterized between ligand bound and free structures PMID; 20661909, for specific isolation of  C35S selenocysteine (SeCys)-containing protein shows the best docking position found, consists of one strand at position [PROline]76:A.side chain: from the four-stranded antiparallel beta sheet was with wild-type TrxA C32-35S located in the Thioredoxin_fold (PDB accession code 1XOB: PMID: 15987909) , TR1 as a single hybrid PDB (Cys32 and Cys35 for Trx1, and for TR1) pubmed/20536427 investigate the possible mechanism. {{{During this reduction, the thiol-disulfide oxidoreductase thioredoxin-1 (Trx1) linkedNADP thioredoxin reductase (TRR2) a working model suggesting that deregulation of the thioredoxin reductase TXNRD1 and|}}} its characteristic substrate thioredoxin (TR [1]), concomitant with diminution of their Trx reductase cellular contents is highly related to glutamate excitotoxicity PMID: 20620191; TR1: hStromelysin-1


 enlargeAn ET (electron transfer) mechanism from NADPH and another enzyme thioredoxin reductase pubmed/17369362 the charged residue aspartate D60 (Fig.2) pubmed/9369469/ plays a role in the degradation of proteins and in apoptotic processes induced by oxidative stress PMID: 16263712  to determine the effect of  zerumbone ZSD1 (from shampoo ginger; Name: Alpha-humulene) on NADP-malate dehydrogenase,NADP TRX dependent oxidoreductase, that NADPH does not contain. Monomeric Thioredoxin is present across phyla from humans to plants PMID: 20661909, 11012661 mediated in vivo by thioredoxin-catalyzed reduction and re-oxidation of cystine residues PubMed id: 10196131 (Fig.3-PDB
: 1CIV, NADP). Trx is able to activate vegetal NADP-malate dehydrogenase PMID: 3170595 (excluding the initial methionine) Met is located at the N-terminal - PMID: 11807942, 2684271. A relatively rigid local configuration for the TRX-aspartate residue D60 is found but which implies that the (NADP-TrxR) protein fluctuates among the numerous protein models and mutations over the time scales fluctuations.




  • Trx (thioredoxin) a redox-regulating protein also controls the antioxidant enzyme activity of the main cellular antioxidant enzymes (AOE) superoxide dismutase (SOD) and catalase.[]

  • (Reference: 1-189)

    Sunday, December 30, 2012

    Human TGF-beta Type II Receptor

    human TbetaR2 ectodomain--TGF-beta3 complex with ELF-3DNATGFBR type II receptors (TGFBR2) are transmembrane tyrosine kinases or associated with cytoplasmic tyrosine kinases** related to resistance to TGF-beta inhibition of cell proliferation and trap TGF-beta I from access to wild-type receptors, the growth-inhibitory and proapoptotic activities of the cytokine, human chromosome 3p22-p21: [§§; , ]. A cysteine-rich wildtypeº SNP-(ancestral C-509T-allele and G-875A variant in TGFBR2) transition (exon 4) not an active mutation in the (constitutional) cDNA extracellular domain transmembrane (ECM) receptors cyclin-dependent kinases (cdks)º also bindsº to TGFBR2. ACVR2 (activin) a GS domain** member of the type II  receptor family ligand-binding domain and TGFBR type II* receptor, and mutations in exon 3 the polyadenine tract (BAT-RII, replication error-RER(+) in exons 4 phenotype, and 10-ACRV2* have premature termination codons (PTCs)-mRNAs can be regulated by miRNAs (endogenous non-coding RNAs) this is a use for inhibitors that can target,  PTC siRNA the effect could silence proteins using any C-terminal such as the gene promotor 5'UTR, mainly in the 3'UTR of mRNA) »» alter the response relative to TGF-beta (a multimer) that inhibits epithelial cell growth, however TGF-beta2 differs in that it binds the TGF-betaR-II isoform restricted to cells of bone-marrow (EC 'vectors') endothelial cells; induction of growth inhibition «« (Morin (flavonol), mannosidase and an molecular Bortezomib PTK/STK characterisation of TβRI suggest a novel mechanism an etoposide Epigallocatechin E.gallate provided by a (G)8, by reaction provides an unusual, C/T allele PKC interaction (autophosphorylation)** that is better able than wild-typeº to induce a the Influenza virus to maintain 3d cohesion of delivery (EGCG) binds with the anti-cancer drug Bortezomib=PMID:17634290dual kinase cytoplasmic domain specificity soluble betaglycan the type III receptor acts as potent type IIº inhibitor) and the loss of trans-phosphorylation or constitutive activation of TGF-beta1 mediated (homozygous and heterozygous polymorphism (heteroduplexes)» functionally related tentative (MMP) involvement of «three major systems as the Marfan syndrome type II gene) growth control or hypophosphorylation.  The functional inactivation of the Germline (Adenoviral -mediated soluble vectors bind and transform cells similar to RB protein retinoblastoma)-gene product (a dominant negatively acting mutant TbetaRIIDN) regulated by TGFBR type II receptors polyadenine (A)(10) tract  can result in microsatellite instability (MSI) of the microsatellite mutator phenotype (MMP) as RER(+), for 'replication errors' exhibiting, somatic type I receptor hereditary mutations ETS transcription factors (Ewing sarcoma EWS and related peripheral primitive tumors, mononucleotide (MSI-H microsatellite instability-high) hereditary TGFBR2 and BAX (G)8 mononucleotide mutation guanine/adenine (G/A) with cytosine/thymine 'C/T' colon tumors) a putative tumor suppressor gene mutations, epithelial-mesenchymal transition (EMT). ETS supression requires functional TGFBR2, truncated type II receptors dominant-negative mutants that selectively block type II receptor signaling to TGF-beta induction (cell ESE ELF3 (ESE1/ESX), ets transcription factor binds to the TGF-beta RII promoter. Autophosphorylationproliferation and differentiation and type I receptors ECM production) by inducing the escape of cells from TGF-beta-mediated growth control in the TGFBR2 gene characterized by germline plus induces secondary somatic mutations. Once the presence of TGFBR2 mutator mechanisms for germline mutations are generated, links (soluble vectors) have a Elf3 'C-terminal' DNA-binding ETS-related domain retroviral (CAT)-construct expressing microsatellite instability (MSI) related to DNA-mismatch repair (MMR proficient and deficiencies) sequences of « Three''' specific small interfering RNAs (siRNAs)''' mono-, di-, and tri-nucleotide repeat hypermutable sequences targets many mRNAs mainly in the 3'UTR''' of mRNA at the poly(A)(10) tract MMR (MRC-1) deficiency, results in intestinal epithelial defects of genes known to be mutated, deoxycytidine (DCK) restores TGF-beta type II receptor (MMR 'initiated' Apc mutation) in many cancer cell lines.

    Tuesday, May 25, 2010

    Placental mammal DPs (Desmoplakin I) in plants and inter-subregion convergent evolutionary strategies of DP2

    Desmoplakin I: [§§] (a protein found in the desmosomes of all epithelia) locus: 6p24, is a member of the plakin family of IF-binding proteins (intermediate filament (IF)) located in the desmosomal plaque, sufficient to cause entry of E2F/DP heterodimer in DRTF1**(TFDP1-transcription factor Dp-1)/E2F quiescent cells to enter S phase in the G1 to S transition. In contrast DPI ultimately resulted in the complete disruption of, a likely constituent of the insoluble cornified cell envelope (CE) homologous to desmoplakin that produces autoantibodies (the autoantigens are members of the subfamily) against IF's, and the associated keratin intermediate filament (KIF) attached to the type I desmosomal-like junction (type II) plaques, resemble; cross-sections of the zonula adherens. Such cell-cell adhesion complexes are a prerequisite for integrity and stability of cells and tissues the most prominent types are the desmosomes. Autoantibodies reacted with an antigen complex composed of desmoplakin I, and the 230-kd antigen comigrated with the tail of the long splice form, a Dsc (desmocollin I) contains sufficient information to recruit desmoplakin and JUP-junction plakoglobin to connexon membrane paracrystals (gap junctions) the retinoblastoma (pRb␠)-E2F/DP pathway at the nuclear envelope region␠ but less is known about envoplakin and periplakin. Being the point of convergence for growth-promoting and growth-inhibitory signals, in cancer chemopreventive effects of green tea (PMID: 11811957) polyphenol epigallocatechin-3-gallate, as few as 86 NH2-terminal DP residues are sufficient to target to desmosomes efficiently, is a component of the carrot (Daucus carota) E2F-like a plant E2F homologue cis-element during the G(1)/S transition, obligatory mammalian cell cycle progression similar to animal DPs in plants E2F. And DP proteins can interact, with this peptide in DSP is, the ¤foreign bioactive peptide¤ of the root hair-promoting (Kunitz trypsin inhibitor (KTI)) peptide(s) and inter-subregion convergent evolutionary strategies. Periplakin NH(2) terminus accumulated at cell surface microvilli. Desmoplakin I proteins mutated the desmosome-associated proteins-PNN, interfere with plakoglobin binding to desmoplakin p0071 (Desmoplakin 4), and localize to the cell membrane in desomosome-forming cell lines at the cell surface, and Dsg3 (desmoglein) were rapidly internalized from the cell surface. PKP1 is required for the formation of clustered structures containing the Dsg1 tail and the DP (desmoplakin), ultrastructurally; appears similar with the non-armadillo head domain of p0071 in contrast to ¤(recurrent bouts of apoptosis and diurnal change and pattern of variation among competitive athlete)¤ VE-cadherin desmoplakin and PP1 (head to tail) association with epidermal keratins that endothelial cells do not have. The CK18 protein as well as periplakin distributed within the cytoplasm were cleaved by caspase 6, cadherin-catenin adhesion complex (such junctions cannot support the formation of desmosomes) in (EMP1)-epithelial adherens junctions* (eg, "rudimentary junctions," "primitive junctions," "desmosome-like junctions") are targeted by caspases (apoptosis**-related cysteine peptidase) upregulating central components with other proteins such as vinculin during apoptosis and can be traced* for several micrometers, three major types of intercellular adhering junctions can be distinguished.